Evolv director sells 80,745 shares at $5.63
Evolv Technologies Holdings director Michael Ellenbogen reported an exercise-and-sell transaction in Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Evolv Technologies Holdings director Michael Ellenbogen reported an exercise-and-sell transaction in Class A Common Stock. He exercised stock options for 80,745 shares at $0.24 per share and sold 80,745 shares at a weighted average price of $5.63 per share under a pre-arranged Rule 10b5-1 trading plan entered into on June 12, 2025, with sale prices ranging from $5.53 to $5.77. Following these transactions, he directly owns 2,083,961 shares and indirectly holds 151,135 shares through the Family Horizon Trust.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 80,745 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 80,745 | $0.24 | $19K |
| Sale | Class A Common Stock | 80,745 | $5.63 | $455K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (3)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.53 to $5.77. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (Right to Buy) financial
Class A Common Stock financial
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Evolv Technologies (EVLV) director Michael Ellenbogen report?
Were Michael Ellenbogen’s Evolv Technologies (EVLV) stock sales pre-planned under Rule 10b5-1?
AI-generated analysis. How Rhea-AI works. Not financial advice.